The role of enzyme replacement therapy in severe Hunter syndrome—an expert panel consensus

Treatment of mucopolysaccharidosis type II (Hunter syndrome) with idursulfase: the relevance of clinical trial end points

(2011) Emma Glamuzina et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Identification of iduronate sulfatase gene alterations in 70 unrelated Hunter patients

(2010) Roseline Froissart et al.   CLINICAL GENETICS

THE NATURAL HISTORY OF THE SEVERE FORM OF HUNTER'S SYNDROME: A STUDY BASED ON 52 CASES

(2010) I. D. Young et al.   DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Home treatment with intravenous enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II — data from the Hunter Outcome Survey

(2010) Barbara K. Burton et al.   MOLECULAR GENETICS AND METABOLISM

Expensive drugs for rare disorders: to treat or not to treat? The case of enzyme replacement therapy for mucopolysaccharidosis VI

(2009) M. Schlander et al.   CURRENT MEDICAL RESEARCH AND OPINION

Bone Marrow Transplantation in Children with Hunter Syndrome: Outcome after 7 to 17 Years

(2009) Nathalie Guffon et al.   JOURNAL OF PEDIATRICS

Home infusion therapy is safe and enhances compliance in patients with mucopolysaccharidoses

(2009) Barbara K. Burton et al.   MOLECULAR GENETICS AND METABOLISM

Multidisciplinary Management of Hunter Syndrome

(2009) J. Muenzer et al.   PEDIATRICS

Transplant Outcomes in Mucopolysaccharidoses

(2009) Vinod K. Prasad et al.   SEMINARS IN HEMATOLOGY

Early response to idursulfase treatment in a 3 year-old boy affected of Hunter syndrome

(2008) Enrique Galán-Gómez et al.   European Journal of Medical Genetics

Home treatment with Elaprase® and Naglazyme® is safe in patients with mucopolysaccharidoses types II and VI, respectively

(2008) S. Bagewadi et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Enzyme Replacement Therapy for Mucopolysaccharidoses: Opinions of Patients and Families

(2008) David J. Coman et al.   JOURNAL OF PEDIATRICS

47. A home infusion protocol for MPS II patients on enzyme replacement therapy (ERT)

(2008) Rachel Katz et al.   MOLECULAR GENETICS AND METABOLISM

Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase

(2008) Paul Harmatz et al.   MOLECULAR GENETICS AND METABOLISM

Recognition and Diagnosis of Mucopolysaccharidosis II (Hunter Syndrome)

(2008) R. Martin et al.   PEDIATRICS

Mucopolysaccharidosis I: Management and Treatment Guidelines

(2008) J. Muenzer et al.   PEDIATRICS